Nasopharyngeal and adjacent neoplasms: a clinico-pathologic and immunologic study

Area of Science:

• Oncology
• Immunology
• Pathology

Background:

• Nasopharyngeal carcinoma (NPC) is a significant malignancy.
• Understanding the immune microenvironment and viral associations is crucial for NPC prognosis.

Purpose of the Study:

• To correlate clinical, immunological, and pathological features with tumor characteristics in NPC and non-NPC nasopharyngeal tumors.
• To investigate the relationship between T- and B-cell distribution, Epstein-Barr virus (EBV) antibody titers, and tumor stage.

Main Methods:

• Clinical, immunological, and pathological investigation of 13 NPC and 16 non-NPC cases.
• TNM classification and correlation with histological type, T- and B-cell distribution (tumor tissue and peripheral blood), and EBV antibody titers.
• Analysis of antibodies against EBV early antigen and capsid antigen.

Main Results:

• Decreased T- and B-cells in tumor tissue and decreased T-cells in peripheral blood correlated with tumor extent in both NPC and non-NPC cases (with exceptions for lymphocyte-rich neoplasms).
• Elevated EBV antibodies (early antigen and capsid antigen) progressively correlated with increasing tumor stage in NPC cases.
• Non-NPC cases did not show a correlation between EBV antibody titers and tumor stage, except for specific NPC histological types (anaplastic carcinoma, lymphoepithelial carcinoma).

Conclusions:

• Tumor-infiltrating lymphocytes and peripheral T-cells are associated with tumor burden in nasopharyngeal malignancies.
• EBV antibody titers serve as a potential biomarker for NPC staging and progression, particularly in specific histological subtypes.